Twist Bioscience Corporation
USD97.72
-0.64 (-0.65%)
CEO
Emily Marine Leproust
IPO Date
2018-10-31
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$99.90
Prev. Close
$98.36
Day Low
$97.65
Day High
$100.39
52W Low
$23.30
52W High
$104.23
Market Cap
$6.09B
Volume
0.21M
| -12.6 |
| 30 Sept 2023 | FY | 36.6% | -83.5% | -32.8% | -26.4% | 0.15 | 5.79 | -5.6 |
| 30 Sept 2022 | FY | 41.4% | -107.0% | -27.6% | -22.7% | 0.12 | 6.58 | -8.7 |
| 30 Sept 2021 | FY | 39.1% | -114.9% | -26.2% | -21.7% | 0.11 | 8.67 | -33.9 |
| 30 Sept 2020 | FY | 31.8% | -155.3% | -41.6% | -35.1% | 0.11 | 9.29 | -21.3 |
| 30 Sept 2019 | FY | 12.8% | -198.0% | -70.8% | -57.6% | 0.05 | 5.28 | -6.1 |
| 30 Sept 2018 | FY | -26.6% | -280.2% | 35.4% | -61.5% | -0.05 | 5.16 | -5.2 |
| 30 Sept 2017 | FY | -123.1% | -550.8% | 44.5% | -69.2% | -0.07 | 7.16 | -4.4 |
| 30 Sept 2016 | FY | -315.2% | -1943.1% | 57.5% | -57.7% | -0.15 | 6.80 | -6.0 |
| -15.9 |
| 30 Sept 2025 | Q4 | 51.3% | -27.4% | -5.7% | -4.2% | 0.29 | 3.64 | -15.7 |
| 30 Jun 2025 | Q3 | 53.4% | 21.2% | 4.3% | 3.2% | 0.16 | 3.90 | 27.1 |
| 31 Mar 2025 | Q2 | 49.6% | -42.4% | -8.9% | -6.6% | 0.18 | 4.51 | -14.9 |
| 31 Dec 2024 | Q1 | 48.3% | -35.6% | -6.9% | -5.2% | 0.18 | 4.96 | -21.8 |
| 30 Sept 2024 | Q4 | 45.1% | -40.9% | -7.3% | -5.6% | 0.18 | 4.88 | -18.9 |
| 30 Jun 2024 | Q3 | 43.3% | -105.0% | -17.4% | -13.4% | 0.18 | 4.91 | -8.3 |
| 31 Mar 2024 | Q2 | 41.0% | -60.4% | -8.1% | -6.5% | 0.16 | 5.51 | -10.9 |
| 31 Dec 2023 | Q1 | 40.5% | -60.2% | -7.3% | -5.9% | 0.16 | 5.98 | -12.3 |